Literature DB >> 32060066

Potential therapeutic targets for lung repair during human ex vivo lung perfusion.

Aaron Wong1, Ricardo Zamel2, Jonathan Yeung2,3, Gary D Bader4, Claudia C Dos Santos1,5, Xiaohui Bai2, Yubo Wang2, Shaf Keshavjee1,2,3,6, Mingyao Liu7,2,3,6.   

Abstract

INTRODUCTION: The ex vivo lung perfusion (EVLP) technique has been developed to assess the function of marginal donor lungs and has significantly increased donor lung utilisation. EVLP has also been explored as a platform for donor lung repair through injury-specific treatments such as antibiotics or fibrinolytics. We hypothesised that actively expressed pathways shared between transplantation and EVLP may reveal common mechanisms of injury and potential therapeutic targets for lung repair prior to transplantation.
MATERIALS AND METHODS: Retrospective transcriptomics analyses were performed with peripheral tissue biopsies from "donation after brain death" lungs, with 46 pre-/post-transplant pairs and 49 pre-/post-EVLP pairs. Pathway analysis was used to identify and compare the responses of donor lungs to transplantation and to EVLP.
RESULTS: 22 pathways were enriched predominantly in transplantation, including upregulation of lymphocyte activation and cell death and downregulation of metabolism. Eight pathways were enriched predominantly in EVLP, including downregulation of leukocyte functions and upregulation of vascular processes. 27 pathways were commonly enriched, including activation of innate inflammation, cell death, heat stress and downregulation of metabolism and protein synthesis. Of the inflammatory clusters, Toll-like receptor/innate immune signal transduction adaptor signalling had the greatest number of nodes and was central to inflammation. These mechanisms have been previously speculated as major mechanisms of acute lung injury in animal models.
CONCLUSION: EVLP and transplantation share common molecular features of injury including innate inflammation and cell death. Blocking these pathways during EVLP may allow for lung repair prior to transplantation.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32060066     DOI: 10.1183/13993003.02222-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.

Authors:  Peng Zhou; Nai-Cheng Song; Zhi-Kun Zheng; Yi-Qing Li; Jin-Song Li
Journal:  BMC Pulm Med       Date:  2022-06-15       Impact factor: 3.320

2.  Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.

Authors:  Roumen Parapanov; Xingyu Wang; Yabo Wang; Anne Debonneville; Jérôme Lugrin; Lucas Liaudet; Thorsten Krueger
Journal:  Transplant Direct       Date:  2022-06-10

3.  Integrated Analysis of Prognostic Genes Associated With Ischemia-Reperfusion Injury in Renal Transplantation.

Authors:  Di Zhang; Yicun Wang; Song Zeng; Min Zhang; Xin Zhang; Yuxuan Wang; Zijian Zhang; Xi Wang; Xiaopeng Hu
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561

4.  Ischemia-Reperfusion Injury in a Simulated Lung Transplant Setting Differentially Regulates Transcriptomic Profiles between Human Lung Endothelial and Epithelial Cells.

Authors:  Gaowa Saren; Aaron Wong; Yun-Bi Lu; Cristina Baciu; Wenyong Zhou; Ricardo Zamel; Sahar Soltanieh; Junichi Sugihara; Mingyao Liu
Journal:  Cells       Date:  2021-10-10       Impact factor: 6.600

Review 5.  Ischemia-Reperfusion Injury in Lung Transplantation.

Authors:  Toyofumi Fengshi Chen-Yoshikawa
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 6.  Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome.

Authors:  Nathan Haywood; Matthew R Byler; Aimee Zhang; Mark E Roeser; Irving L Kron; Victor E Laubach
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

7.  Thyroidal Transcriptomic Profiles of Pathoadaptive Responses to Congenital Hypothyroidism in XB130 Knockout Mice.

Authors:  Junichi Sugihara; Aaron Wong; Hiroki Shimizu; Jinbo Zhao; Hae-Ra Cho; Yingchun Wang; Samuel Refetoff; Peter Arvan; Mingyao Liu
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.